Dayvigo

(lemborexant)

lemborexant 10 MG Oral Tablet [Dayvigo]lemborexant 5 MG Oral Tablet [Dayvigo]

NO BLACK BOX WARNING

Dosage & administration

* Recommended dose is 5 mg taken no more than once per night, immediately before going to bed, with at least 7 hours remaining before the planned time of awakening. Dosage may be increased to 10 mg based on clinical response and tolerability.

* The maximum recommended dose is 10 mg once daily.

* Time to sleep onset may be delayed if taken with or soon after a meal.

* Hepatic Impairment:
○ Moderate hepatic impairment: Initial and maximum recommended dosage is 5 mg no more than once per night.
○ Severe hepatic impairment: Not recommended.

drug label

Dayvigo prescribing information

Contact Medical Science Liaison Report Adverse Event

samples

Request Dayvigo samples

Online Sample Form

Learn More

prior authorization

Dayvigo prior authorization resources

PDFComplete Letter of Medical Necessity

PDFCoverage Authorization Appeals

Prior Authorization Form

Learn More

financial assistance

Dayvigo financial assistance options

Co-pay savings program

commercial only

OTHEREnroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Foundation programs

under insured

no insurance

goverment insurance

65+

PDFDayvigo Patient Assistance Program Application

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.